A new analysis of clinical trial data led by Anisha P. Ganguly, MD, MPH, a general internist at UNC Health and member of UNC Lineberger Comprehensive Cancer Center, has proven that mailed fecal immunochemical tests can drastically ...
20 hours ago
0
2
A research letter from experts at the University of Chicago Medicine, published in JAMA Oncology, warns that upcoming funding cuts and changes to federal Medicaid eligibility rules could lead to dramatic reductions in cancer ...
May 2, 2026
0
7
People living in areas with fewer resources are less likely to receive cancer screenings from federal clinics, according to a recent study from the University of Georgia published in the Journal of General Internal Medicine.
Apr 29, 2026
0
3
A national survey study led by UCLA Health and Cedars-Sinai Medical Center has found significant disparities in how irritable bowel syndrome (IBS) is diagnosed across sex and racial groups in the U.S., with men and Black ...
Apr 9, 2026
0
3
The death of US actor James Van Der Beek was just the latest reminder that colorectal cancer has been surging among people under 50 in recent years—and no one knows why.
Feb 17, 2026
0
5
Colon cancer is now the No. 1 cause of cancer deaths in Americans under 50. It claimed that spot seven years earlier than previously projected. Colon cancer deaths among people under 50 have risen roughly 1% each year since ...
Jan 23, 2026
0
30
UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended screening age to 45 from ...
Nov 19, 2025
0
10
If you adopt a healthier lifestyle after bowel screening, it can lower your risk of both bowel cancer and other chronic diseases, a new study shows.
Oct 2, 2025
0
16
New Jersey has the 10th-highest rate of cancer incidence in the United States. It is the second leading cause of death in New Jersey, and thousands of residents die from preventable cancers each year.
Sep 19, 2025
0
14
A randomized controlled trial aimed to determine whether providing information on patient risk for advanced colorectal neoplasia (ACN) to patients and providers affects colorectal cancer (CRC) screening uptake.
Sep 1, 2025
0
13
